Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evaluation of results 1 year following short-term use of ranibizumab for vitreous hemorrhage due to proliferative diabetic retinopathy.

× No keyword cloud information.

2 in total

1. The prevalence of diabetic retinopathy among adults in the United States.

Authors: John H Kempen; Benita J O'Colmain; M Cristina Leske; Steven M Haffner; Ronald Klein; Scot E Moss; Hugh R Taylor; Richard F Hamman
Journal: Arch Ophthalmol Date: 2004-04

2. Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.

Authors:
Journal: JAMA Ophthalmol Date: 2013-03 Impact factor: 7.389

2 in total

11 in total

Review 1. Recent advancements in diabetic retinopathy treatment from the Diabetic Retinopathy Clinical Research Network.

Authors: Carl W Baker; Yi Jiang; Thomas Stone
Journal: Curr Opin Ophthalmol Date: 2016-05 Impact factor: 3.761

2. Intravitreal Bevacizumab for the Treatment of Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy.

Authors: Rupin N Parikh; Anastasia Traband; Anton M Kolomeyer; Brian L VanderBeek; Benjamin J Kim; Albert M Maguire; Alexander J Brucker
Journal: Am J Ophthalmol Date: 2017-01-24 Impact factor: 5.258

3. Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.

Authors: Irini Chatziralli; Eleni Dimitriou; George Theodossiadis; Evgenia Bourouki; Eleni Bagli; George Kitsos; Panagiotis Theodossiadis
Journal: Int Ophthalmol Date: 2019-12-02 Impact factor: 2.031

4. Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.

Authors: Andrew N Antoszyk; Adam R Glassman; Wesley T Beaulieu; Lee M Jampol; Chirag D Jhaveri; Omar S Punjabi; Hani Salehi-Had; John A Wells; Maureen G Maguire; Cynthia R Stockdale; Daniel F Martin; Jennifer K Sun
Journal: JAMA Date: 2020-12-15 Impact factor: 56.272

5. The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects.

Authors: Cengiz Alagöz; Yusuf Yıldırım; Murat Kocamaz; Ökkeş Baz; Uğur Çiçek; Burcu Çelik; Halil İbrahim Demirkale; Ahmet Taylan Yazıcı; Muhittin Taşkapılı
Journal: Turk J Ophthalmol Date: 2016-10-17

Review 6. Ranibizumab in the Treatment of Diabetic Macular Edema: A Review of the Current Status, Unmet Needs, and Emerging Challenges.

Authors: Nikolaos Dervenis; Athanasia Maria Mikropoulou; Paris Tranos; Panagiotis Dervenis
Journal: Adv Ther Date: 2017-05-08 Impact factor: 3.845

7. Efficacy of ranibizumab for the treatment of diabetic retinopathy: A protocol for systematic review of randomized controlled trial.

Authors: Yong-Bo Ren; Xing-Jie Su; Yan-Xiu Qi; He-Qun Luan; Qi Sun
Journal: Medicine (Baltimore) Date: 2019-04 Impact factor: 1.817

8. Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.

Authors: Ahmed Hosni Abd Elhamid; Ahmed Abd El Alim Mohamed; Abeer Mohamed Khattab
Journal: BMC Ophthalmol Date: 2020-04-06 Impact factor: 2.209

Review 9. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.

Authors: Jonathan M Smith; David H W Steel
Journal: Cochrane Database Syst Rev Date: 2015-08-07

10. Multiple factors in the prediction of risk of recurrent vitreous haemorrhage after sutureless vitrectomy for non-clearing vitreous haemorrhage in patients with diabetic retinopathy.

Authors: Yuhua Ding; Bangtao Yao; Hui Hang; Hui Ye
Journal: BMC Ophthalmol Date: 2020-07-16 Impact factor: 2.209